US launches probe into Germany's drug pricing rules, raising prospect of fresh tariffs
The United States has initiated a formal investigation into Germany's pharmaceutical pricing framework, citing concerns over market access. The probe could result in retaliatory tariffs, intensifying US-European trade friction.